MétaCan
Menu
Back to cohort
Record W4417441826 · doi:10.26685/urncst.890

Single-Cell Sequencing and Multi-Omic Technologies in Acute Myeloid Leukemia: A Literature Review

2025· review· W4417441826 on OpenAlexaff

Bibliographic record

VenueUndergraduate Research in Natural and Clinical Science and Technology (URNCST) Journal · 2025
Typereview
Language
FieldBiochemistry, Genetics and Molecular Biology
TopicSingle-cell and spatial transcriptomics
Canadian institutionsQueen's University
Fundersnot available
KeywordsEpigenomicsMyeloid leukemiaTranscriptomeMyeloidProteomicsHaematopoiesisDiseaseProgenitor cellCEBPAIdentification (biology)

Abstract

fetched live from OpenAlex

Acute Myeloid Leukemia (AML) exemplifies leukemogenesis as a multistep process in which healthy hematopoietic stemand progenitor cells (HSPCs) acquire sequential genetic and molecular alterations, leading to malignant transformation.Traditional bulk sequencing approaches, although informative, cannot resolve the extensive cellular heterogeneity withinAML. The application of single-cell RNA sequencing (scRNA-seq)—as shown by Wu et al.—enables the identification ofdistinct differentiation pathways and gene expression profiles at the individual cell level, which are specific to AML subtypesand relate to disease progression. When combined with advanced surface proteomics techniques such as Cellular Indexing ofTranscriptomes and Epitopes by sequencing (CITE-seq), single-cell profiling offers comprehensive insights into AML’scellular architecture, revealing cell surface markers linked to proliferation, migration, and treatment resistance. Integration ofmulti-omic layers—including transcriptomic, epigenomic, and proteomic data—has been further advanced in chromatinaccessibility profiling, collectively aiding in the discovery of innovative therapeutic targets and enhancing diagnosticstrategies. Comprehensive literature searches across PubMed, Cochrane, and Google Scholar were performed to select studieson single-cell and multi-omic analyses in human AML, focusing on work published from 2014 onward. Studies emphasizingleukemic subtypes, differentiation pathways, and novel therapeutic targets were prioritized, with particular attention to recentconceptual and technological advancements in AML research. Recent work by Clark et al. and others has uncoveredpreviously unrecognized AML subpopulations with unique differentiation states and genetic alterations implicated in diseaseprogression and therapy resistance. The integration of transcriptomic and epigenomic data has clarified molecular pathwaysand transcriptional regulators key to leukemic cell survival and proliferation. These advances have substantially deepened ourunderstanding of AML cellular heterogeneity, providing new insight into the mechanisms behind disease evolution andtreatment response. The application of single-cell and multi-omic approaches in AML marks a pivotal advance towardpersonalized medicine. By enabling the identification of AML subtypes, refining risk stratification, and supporting real-timedisease monitoring, these technologies now facilitate the development of targeted therapies tailored to individual molecularprofiles, ultimately improving patient outcomes and guiding clinical decision-making.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.010
metaresearch head score (Gemma)0.005
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesMeta-epidemiology (narrow), Science and technology studies, Research integrity
Consensus categoriesResearch integrity
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Other design · Consensus signal: none
GenreCandidate signal: Review · Consensus signal: Review
Teacher disagreement score0.965
Threshold uncertainty score1.000

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0100.005
Meta-epidemiology (narrow)0.0010.001
Meta-epidemiology (broad)0.0020.000
Bibliometrics0.0030.007
Science and technology studies0.0010.009
Scholarly communication0.0010.000
Open science0.0020.002
Research integrity0.0030.012
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.062
GPT teacher head0.391
Teacher spread0.329 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; both teacher heads agree on what is shown here.

Study designOther design
Domainnot available
GenreReview

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2025
Admission routes1
Has abstractyes

Explore more

Same venueUndergraduate Research in Natural and Clinical Science and Technology (URNCST) JournalSame topicSingle-cell and spatial transcriptomicsFrench-language works237,207